Huntingtons Disease disease mechanism in adults
Huntington’s disease (HD) is a devastating neurodegenerative disorder primarily affecting adults, characterized by a gradual decline in motor control, cognitive abilities, and psychiatric health. Its underlying disease mechanism involves a complex interplay of genetic mutations, protein misfolding, neuronal dysfunction, and eventual cell death, leading to the progressive symptoms observed in patients.
At the core of Huntington’s disease is a genetic mutation in the HTT gene, which encodes the huntingtin protein. This mutation involves an abnormal expansion of CAG trinucleotide repeats within the gene. While individuals with fewer than approximately 35 repeats typically do not develop the disease, those with 36 or more repeats are at risk, with larger expansions correlating with earlier onset and more severe symptoms. This genetic anomaly results in the production of an abnormal huntingtin protein containing an elongated polyglutamine tract.
The expanded polyglutamine segment in mutant huntingtin is prone to misfolding and aggregation. These aggregates accumulate within neurons, particularly in the basal ganglia—most notably the striatum—and the cerebral cortex. The formation of these insoluble protein aggregates disrupts cellular homeostasis, interfering with normal protein function, impairing cellular transport mechanisms, and disrupting the balance of calcium ions, which are crucial for neuronal signaling.
One of the key consequences of mutant huntingtin accumulation is its toxic gain-of-function effect. Mutant huntingtin interacts aberrantly with various cellular proteins, disrupting multiple signaling pathways and cellular processes. It impairs mitochondrial function, leading to reduced energy production and increased susceptibility to oxidative stress. Mitochondrial dysfunction is especially detrimental in neurons, which are highly energy-dependent, and contributes to neuronal vulnerability and death.
Another critical aspect involves the impairment of the ubiquitin-proteasome system and autophagy, the cell’s mechanisms for clearing misfolded proteins. When these pathways are overwhelmed or dysfunctional, mutant huntingtin and other damaged proteins accumulate further, exacerbating cellular stress and promoting apoptosis—programmed cell death.
Neuronal death in Huntington’s disease is largely mediated through apoptosis and other forms of cell death such as necrosis and autophagy-related pathways. The loss of medium spiny neurons in the striatum results in the hallmark motor symptoms, including chorea, dystonia, and impaired coordination. Meanwhile, cortical neuron degeneration contributes to cognitive decline and psychiatric disturbances.
The disease progression is also influenced by neuroinflammatory responses. Activated microglia and astrocytes release cytokines and other inflammatory mediators, which can further damage neurons. This neuroinflammation perpetuates a cycle of neurodegeneration, worsening the clinical picture.
In summary, Huntington’s disease in adults is driven by a genetic mutation that leads to the production of a toxic, misfolded huntingtin protein. This protein causes widespread neuronal dysfunction and death through mechanisms involving protein aggregation, mitochondrial impairment, disrupted cellular clearance pathways, and neuroinflammation. Understanding these processes not only clarifies the disease’s pathogenesis but also guides the development of targeted therapies aimed at halting or slowing disease progression.
